ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Geriatric Medicine

Top Geriatric Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CRISTINA BOCIRNEA MD

Geriatric Medicine

2,116

$176K

45
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$83
Average prescription price

Avg: $64

GERALDINE SALMERON MD

Geriatric Medicine

1,740

$130K

58
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $64

GUILFORD ROBINSON M.D.

Geriatric Medicine

8,870

$685K

222
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$77
Average prescription price

Avg: $64

ANIL GARYALI M.D.

Geriatric Medicine

17,509

$1.05M

272
236 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

KHOREN HEKIMIAN DO

Geriatric Medicine

67,122

$4.67M

1287
946 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $64

FOLASADE OJO MD

Geriatric Medicine

26,715

$1.73M

514
416 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $64

JIBRAIL KASPERKHAN M.D.

Geriatric Medicine

44,085

$3.03M

760
682 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

RADU CIUBUC MD

Geriatric Medicine

33,861

$2.47M

845
749 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $64

JAEE NAIK MD

Geriatric Medicine

3,068

$265K

108
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$86
Average prescription price

Avg: $64

GEORGE ROBISON M.D.

Geriatric Medicine

2,432

$176K

93
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $64

CHARLES MAXVILL DO

Geriatric Medicine

56,911

$3.64M

1085
900 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $64

ARUNA AGRAHARKAR MD

Geriatric Medicine

4,399

$276K

122
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $64

RICHARD STRICKLAND M.D.

Geriatric Medicine

10,458

$558K

280
264 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $64

OMAR ZANTUA M.D.

Geriatric Medicine

25,352

$2M

469
419 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $64

RODNEY CARRY MD

Geriatric Medicine

3,559

$192K

179
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $64

MELCHOR ACOSTA MD

Geriatric Medicine

24,697

$1.41M

522
459 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $64

MARY MAXWELL M.D.

Geriatric Medicine

6,978

$437K

158
147 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $64

PEGGY RUSSELL D.O.

Geriatric Medicine

12,363

$680K

429
391 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $64

NORBERTO MONTANI MD

Geriatric Medicine

7,179

$432K

276
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

NEETA NAYAK MD

Geriatric Medicine

29,948

$1.75M

739
611 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $64

BIJU OOMMEN M.D.

Geriatric Medicine

23,664

$1.34M

681
599 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $64

UZMA RAHAT M.D

Geriatric Medicine

4,019

$241K

185
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

ILSONG CHONG M.D.

Geriatric Medicine

15,757

$938K

448
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

THEODORE TRUMBLE M.D.

Geriatric Medicine

6,355

$338K

178
170 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $64

REZIUDDIN SIDDIQUE M. D.

Geriatric Medicine

43,748

$2.66M

1039
860 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank